Compare COLB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COLB | RGEN |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | COLB | RGEN |
|---|---|---|
| Price | $28.56 | $158.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $29.50 | ★ $177.18 |
| AVG Volume (30 Days) | ★ 2.0M | 600.1K |
| Earning Date | 01-22-2026 | 02-19-2026 |
| Dividend Yield | ★ 5.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.20 | 0.03 |
| Revenue | ★ $1,916,444,000.00 | $707,890,000.00 |
| Revenue This Year | $27.29 | $17.86 |
| Revenue Next Year | $21.84 | $12.44 |
| P/E Ratio | ★ $13.12 | $6,367.21 |
| Revenue Growth | 4.82 | ★ 11.74 |
| 52 Week Low | $19.61 | $102.97 |
| 52 Week High | $29.72 | $182.52 |
| Indicator | COLB | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.61 | 45.38 |
| Support Level | $28.04 | $158.80 |
| Resistance Level | $29.39 | $165.30 |
| Average True Range (ATR) | 0.65 | 6.12 |
| MACD | -0.05 | -0.95 |
| Stochastic Oscillator | 48.73 | 22.13 |
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.